07.20.23 | News
RENOVUS
2023
Mid-Year in Review
And just like that, we have reached the midpoint of 2023. While the pace of market activity has eased from its peak, Renovus continues to work with intensity. Our first half highlights include new platform investments, add-on acquisitions, continued expansion and promotions of the team, programmatic efforts across the portfolio, the publication of our inaugural impact report, the launch of multiple exit processes and several LP-focused initiatives.
We are proud to report that Renovus was ranked #1 in a worldwide study of small-cap buyout firms (up from #3 last year, noted below).1 We have achieved our success through the committed work of our 26 professionals (soon to be 29). We are executing on the Renovus playbook with our portfolio companies, professionalizing their operations and building their management teams to fuel additional organic growth and integrate strategic add-ons. Renovus continues to evolve as a firm, with additional focus on culture and core values while always working toward our shared team goals.
Read the details of our mid-year review below. We are looking forward to the remainder of 2023!
Firm Updates
New Platform Investments
Renovus invested more than $70 million in three new platform investments.
DataServ is a preeminent provider of managed technology, connectivity, and security services. The Company’s unique “IT as a utility” approach simplifies the access, use, and management of technology and is tailormade for customers in education, government, healthcare and other highly-regulated commercial markets.
Renovus created a new platform through the combination of F2 Strategy and Oakbrook Solutions. Together, they are the largest WealthTech management consulting firm in North America helping complex RIA, wealth, bank/trust and family office firms improve their technical capabilities to build exceptional client and advisor experiences.
TJP is a leading healthcare marketing communications and sales training consultant. TJP serves several large global pharmaceutical companies in the highly specialized area of payer marketing as well as access and affordability program design, implementation and management.
Add-on Acquisitions
In addition, Renovus’ existing platform investments achieved greater scale through making multiple strategic add-on acquisitions:
Renovus Platform
Industry Vertical
Add-on Acquisition
Team Growth
Renovus continues to build the team in 2023. Please contact recruiting@renovuscapital.com if you are interested or would like to recommend someone.
Looking to the Second Half of 2023
Renovus is well-positioned for continued success in the second half of the year. The firm has a strong pipeline of investment opportunities, and we expect it to be a very active summer and fall! We are exploring several new initiatives, including formalizing our operating partner program. If you are interested or know someone would be a good operating partner, please let us know!
We are committed to the continued success of the firm for our limited partners, portfolio companies, key stakeholders and Renovus team members. We look forward to working with you throughout the rest of the year.